European Journal of Medicinal Chemistry
Encyclopedia
The European Journal of Medicinal Chemistry is a peer-reviewed
scientific journal
for medicinal chemistry
. It started in 1966 under the title Chimica Therapeutica (CODEN
CHTPBA). This name was maintained until 1973 and in 1974 it changed to its current title. From 1974 to 1981 the journal was still subtitled as Chimica Therapeutica; from 1982 to 1986 the subtitle was Chimie Therapeutique, indicating its French origin.
The Journal publishes studies on all aspects of medicinal chemistry
: organic synthesis
; biological behavior; pharmacological activity; drug design
; QSAR; molecular modeling; drug-receptor interactions; molecular aspects of drug metabolism; prodrug synthesis and drug targeting. The journal welcomes papers from any country, Europe, North America or otherwise, and provides a medium for publication of original papers, laboratory notes, short or preliminary communications, and invited reviews.
The European Journal of Medicinal Chemistry is published by Elsevier
.
Peer review
Peer review is a process of self-regulation by a profession or a process of evaluation involving qualified individuals within the relevant field. Peer review methods are employed to maintain standards, improve performance and provide credibility...
scientific journal
Scientific journal
In academic publishing, a scientific journal is a periodical publication intended to further the progress of science, usually by reporting new research. There are thousands of scientific journals in publication, and many more have been published at various points in the past...
for medicinal chemistry
Medicinal chemistry
Medicinal chemistry and pharmaceutical chemistry are disciplines at the intersection of chemistry, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where it is involved with design, chemical synthesis and development for market of pharmaceutical...
. It started in 1966 under the title Chimica Therapeutica (CODEN
CODEN
CODEN – according to ASTM standard E250 – is a six character, alphanumeric bibliographic code, that provides concise, unique and unambiguous identification of the titles of serials and non-serial publications from all subject areas....
CHTPBA). This name was maintained until 1973 and in 1974 it changed to its current title. From 1974 to 1981 the journal was still subtitled as Chimica Therapeutica; from 1982 to 1986 the subtitle was Chimie Therapeutique, indicating its French origin.
The Journal publishes studies on all aspects of medicinal chemistry
Medicinal chemistry
Medicinal chemistry and pharmaceutical chemistry are disciplines at the intersection of chemistry, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where it is involved with design, chemical synthesis and development for market of pharmaceutical...
: organic synthesis
Organic synthesis
Organic synthesis is a special branch of chemical synthesis and is concerned with the construction of organic compounds via organic reactions. Organic molecules can often contain a higher level of complexity compared to purely inorganic compounds, so the synthesis of organic compounds has...
; biological behavior; pharmacological activity; drug design
Drug design
Drug design, also sometimes referred to as rational drug design or structure-based drug design, is the inventive process of finding new medications based on the knowledge of the biological target...
; QSAR; molecular modeling; drug-receptor interactions; molecular aspects of drug metabolism; prodrug synthesis and drug targeting. The journal welcomes papers from any country, Europe, North America or otherwise, and provides a medium for publication of original papers, laboratory notes, short or preliminary communications, and invited reviews.
The European Journal of Medicinal Chemistry is published by Elsevier
Elsevier
Elsevier is a publishing company which publishes medical and scientific literature. It is a part of the Reed Elsevier group. Based in Amsterdam, the company has operations in the United Kingdom, USA and elsewhere....
.